KILLA ACNE EXTRA STRENGTH 2 PACK- salicylic acid patch
ZitSticka, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Salicylic Acid 2%

Ask a doctor if irritation become severe.

Keep out of reach of children. If swallowed, get medical help or contact a posion Control Center right away.

Uses:

For the management of acne.
Penetrates pores to eliminate most blemishes.

Sodium Hyaluronate, phytosphingosine HCl, Niacinamide, Oligopeptide-10, Glycolic Acid, Madecassoside, 4-Butylresorcinol

Uses

For the management of acne.
Penetrates pores to eliminate most blemishes.

Directions and How to Use

How to open:

1. To remove a patch, peel the front, top corner and pull towards the center.

2. Inside, you'll find a white tab with a slit on one side. Tear along that seam to reveal the KILLA ACNE Extra Strength patch.

How to use:

1. Cleanse skin thoroughly before applying the product.

2. Once dry, apply KILLA ACNE Extra Strength pimple patch onto zit.

3. Leave on for 2+ hrs for microdarts to dissolve (for best results leave on overnight).

For external use only.

PDP

KILLA ACNE EXTRA STRENGTH 2 PACK
salicylic acid patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:81746-899
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.0125 mg in 0.6216 mg

Ingredient Name	Strength
Inactive Ingredients
4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA)
PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)
GLYCOLIC ACID (UNII: 0WT12SX38S)
OLIGOPEPTIDE-10 (UNII: Q46328TRNK)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
MADECASSOSIDE (UNII: CQ2F5O6YIY)
NIACINAMIDE (UNII: 25X51I8RD4)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:81746-899-00	1660 mg in 1 BOX; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)	08/30/2023

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph final	M006	05/26/2023

Labeler - ZitSticka, Inc. (117778611)

Name	Address	ID/FEI	Business Operations
Establishment
Raphas		695914964	manufacture(81746-899)